Bergen, P.F.M.M. van

infarction patient anticoagulant anticoagulant treatment treatment trial mortality event study anticoagulant therapy therapy effect group chapter placebo result hospital analysis reduction randomised table aspect death heart factor follow-up thrombosis number disease complication aspect trial discharge thrombolytic stroke aspirin non-participant thrombolytic therapy subgroups admission participant ratio hospital survivors anticoagulated cerebro-vascular diabetes prevention reinfarction month interval meta-analysi double-blind cerebro-vascular event confidence research survivor lancet multivariable survival subgroup class centre estimate medication score randomised trials prognosis placebo patients figure population anticoagulated patients category variable endpoints infarction injury score patienten comparison benefit onderzoek incidence smoking